Advances in PH Journal
Advances in Pulmonary Hypertension Summer 2003 (Vol 2, No 2)
- Editor's Memo: PAH-Associated Congenital Heart Disease: Finding Common Ground With Primary Pulmonary Hypertension
As we planned this issue on pulmonary arterial hypertension (PAH) in congenital heart disease and in children, we sensed the long shadows of physicians who have helped establish the parameters of its diagnosis.
- Profiles in Pulmonary Hypertension: Remembering Paul Wood: Relentlessly Driven, Dazzling Diagnostician
Forty years after he died at the tragically early age of 54, the reputation of Dr Paul Wood as a showman and consummate physician, so dazzling in his ability to diagnose that he is recognized as one of the greatest diagnosticians ever, still serves as a reminder of what he means to contemporary cardiology.
- Pulmonary Hypertension in Children: New Insights Offer Opportunity to Reverse the Disease Process
Severe, sustained pulmonary hypertension is potentially fatal. It is, however, time to adopt a more positive and aggressive approach to the management of pulmonary hypertension in children.
- Eisenmenger Syndrome in Adults: Strategies to Correct Congenital Defects Before Fixed Vascular Disease Develops
Congenital heart defects (CHDs) associated with large systemicto- pulmonary shunts, (eg, atrial septal defect, ventricular septal defect, patent ductus arteriosus) can lead to pulmonary vascular disease, which is characterized by bidirectional shunting or reversal of the shunt.
- Pulmonary Hypertension Roundtable- Pulmonary Arterial Hypertension in Congenital Heart Disease: Controversies and Consensus
Four physicians discussed current and future strategies for the assessment and treatment of pulmonary arterial hypertension (PAH) related to congenital heart disease.
